Depomed Receives FDA Approval of Proquin XR for Uncomplicated Urinary Tract Infections (RedNova)

home   >   yahoo news

Depomed, Inc. (Nasdaq:DEPO) announced today that it has received approval from the United States Food and Drug Administration (FDA) for Proquin(TM) XR, a once-daily, extended-release formulation of ciprofloxacin hydrochloride for the treatment of uncomplicated urinary tract infections (UTIs).

- link to Depomed Receives FDA Approval of Proquin XR for Uncomplicated Urinary Tract Infections (RedNova) -
Last update: 06/01/2005

Recommended Reading

    The Cipro Rip-Off. (The Front).(Bayer Corp.) : An article from: Multinational Monitor
    Campfire Cats Blue Ridge Smoky Mountain Hiking Guide and Journal
    Cipro May Be First Drug Approved for Anthrax.(Brief Article) : An article from: Family Practice News
    Web site helps you avoid Cipro, anthrax test kit scams.(News) : An article from: Daily Herald (Arlington Heights, IL)
    Cipro: A Medical Dictionary, Bibliography, and Annotated Research Guide to Internet References
    Lonely Planet: Cipro
    Cipro May Be First Drug Approved for Anthrax.(Brief Article) : An article from: Family Practice News
    Cipro.(New & Approved) : An article from: Pediatric News